SCHEMBL17793545

SCHEMBL17793545

CC(=O)[C@H](Cc1ccccc1)NO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
CTSS P25774 1/20 0.50
CTSK P43235 1/20 0.50
MMP9 P14780 1/20 0.50
MMP8 P22894 1/20 0.50
MMP14 P50281 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
PAM P19021 1/20 0.50
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
SLC7A5 Q01650 1/20 0.50
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
CTRB1 P17538 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8175870 0.85 TAAR1 (0.52) ALDH1A1CTSSCTSKNPC1RAB9A
SCHEMBL5721934 0.85 EPHX1 (0.55) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL8318346 0.85 TAAR1 (0.52) ALDH1A1CTSSCTSKNPC1RAB9A
SCHEMBL1803033 0.85 EPHX1 (0.55) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL18494069 0.85 EPHX1 (0.55) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL2628426 0.85 TAAR1 (0.52) ALDH1A1CTSSCTSKNPC1RAB9A
SCHEMBL891433 0.84 MME (0.59) MMP9CYP1A2L3MBTL1MME
SCHEMBL9508136 0.84 MME (0.59) MMP9CYP1A2L3MBTL1MME
SCHEMBL891432 0.84 MME (0.59) MMP9CYP1A2L3MBTL1MME
Water SCHEMBL9506493 0.83 EPHX1 (0.53) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160151508-A1 PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING PURDUE RESEARCH FOUNDATION 2016-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160151508-A1 PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING FOLH1, KLK3, PSMA1 ALDH1A1 2748/4885CTSS 1452/4885CTSK 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.